AETHLON MEDICAL INC (AEMD) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US00808Y6041

Price
5.58 USD
Market cap
8.95 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
-146.36 %
Return on assets (ROA)
-112.92 %

AETHLON MEDICAL INC financials

Fiscal year20252026
Operating income-9.34 m USD-7.29 m USD
EBIT-13.38 m USD-7.29 m USD
Net income-13.39 m USD-7.15 m USD
Diluted EPS – continuing operations-8.58 USD-10.61 USD

Full history since 2010, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About AETHLON MEDICAL INC

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.